Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

OraSure Technologies, Inc. (OSUR)

Compare
3.1100
-0.1100
(-3.42%)
At close: April 4 at 4:00:02 PM EDT
3.1100
0.00
(0.00%)
After hours: April 4 at 4:05:09 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
185,827
185,827
405,472
387,479
233,674
Cost of Revenue
106,437
106,437
233,820
239,041
116,074
Gross Profit
79,390
79,390
171,652
148,438
117,600
Operating Expense
103,248
103,248
128,238
153,681
129,249
Operating Income
-23,858
-23,858
43,414
-5,243
-11,649
Other Income Expense
7,857
7,857
12,844
-10,432
2,357
Pretax Income
-16,001
-16,001
56,258
-15,675
-9,292
Tax Provision
1,799
1,799
2,603
1,458
13,706
Earnings from Equity Interest Net of Tax
-1,700
-1,700
--
--
--
Net Income Common Stockholders
-19,500
-19,500
53,655
-17,133
-22,998
Diluted NI Available to Com Stockholders
-19,500
-19,500
53,655
-17,133
-22,998
Basic EPS
0.15
-0.26
0.73
-0.25
-0.32
Diluted EPS
0.15
-0.26
0.72
-0.25
-0.32
Basic Average Shares
74,122
74,434
73,348
72,505
71,981
Diluted Average Shares
74,488.7500
74,434
74,389
72,505
71,981
Total Operating Income as Reported
-28,250
-28,250
32,684
-22,156
-10,164
Total Expenses
209,685
209,685
362,058
392,722
245,323
Net Income from Continuing & Discontinued Operation
-19,500
-19,500
53,655
-17,133
-22,998
Normalized Income
-16,030.3200
-16,030.3200
63,888.5339
-3,771.7300
-24,082.0500
EBIT
-23,858
-23,858
43,414
-5,243
-11,649
EBITDA
-13,550
-13,550
64,353
10,293
846
Reconciled Cost of Revenue
106,437
106,437
233,820
239,041
116,074
Reconciled Depreciation
10,308
10,308
20,939
15,536
12,495
Net Income from Continuing Operation Net Minority Interest
-19,500
-19,500
53,655
-17,133
-22,998
Total Unusual Items Excluding Goodwill
-4,392
-4,392
-10,730
-16,913
1,485
Total Unusual Items
-4,392
-4,392
-10,730
-16,913
1,485
Normalized EBITDA
-9,158
-9,158
75,083
27,206
-639
Tax Rate for Calcs
0.0002
0.0002
0
0.0002
0.0003
Tax Effect of Unusual Items
-922.3200
-922.3200
-496.4661
-3,551.7300
400.9500
12/31/2021 - 11/17/1986

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BLFS BioLife Solutions, Inc.
20.88
-6.95%
 
UTMD Utah Medical Products, Inc.
54.83
-0.44%
 
HBIO Harvard Bioscience, Inc.
0.4003
-15.44%
 
DXR Daxor Corporation
7.64
-3.66%
 
GRRMF Gerresheimer AG
69.75
-5.68%
 
EKSO Ekso Bionics Holdings, Inc.
0.3780
-9.72%
 
KRMD KORU Medical Systems, Inc.
2.2800
-3.39%
 
RVP Retractable Technologies, Inc.
0.6800
-0.73%
 
NEPH Nephros, Inc.
2.0400
-5.12%
 
AKYA Akoya Biosciences, Inc.
1.1700
-4.10%